These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12228844)

  • 1. Rationale for combination therapy in the treatment of hypertension.
    Sica DA
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):63-5. PubMed ID: 12228844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacology of antihypertensive therapy.
    Taylor AA; Pool JL
    Semin Nephrol; 2005 Jul; 25(4):215-26. PubMed ID: 16202694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of single-pill combination therapy in the evolving paradigm of hypertension management.
    Calhoun DA
    Expert Opin Pharmacother; 2009 Aug; 10(12):1869-74. PubMed ID: 19496740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertension.
    Jamerson KA; Bakris GL; Wun CC; Dahlöf B; Lefkowitz M; Manfreda S; Pitt B; Velazquez EJ; Weber MA
    Am J Hypertens; 2004 Sep; 17(9):793-801. PubMed ID: 15363822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME; Epstein BJ
    J Cardiovasc Nurs; 2009; 24(5):380-9. PubMed ID: 19707098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing hypertension management in clinical practice.
    Heagerty A
    J Hum Hypertens; 2006 Nov; 20(11):841-9. PubMed ID: 16915300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockers in hypertension. Is there still a controversy?
    Izzo JL
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):1-5. PubMed ID: 16640168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic implications of recent megatrials in hypertension: in favor of new drugs.
    Volpe M; Tocci G
    J Nephrol; 2007; 20 Suppl 12():S12-8. PubMed ID: 18050137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial combination therapy for rapid and effective control of moderate and severe hypertension.
    Franklin SS; Neutel JM
    J Hum Hypertens; 2009 Jan; 23(1):4-11. PubMed ID: 18615100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The frequent need for three or more drugs to treat essential hypertension. What evidence for optimal combinations?
    Swift PA; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):103-8. PubMed ID: 12228850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial therapy for uncomplicated hypertension: insights from the alphabetic maze of recent studies.
    Stewart JR; Yeun JY
    Minerva Med; 2003 Aug; 94(4):215-27. PubMed ID: 14605587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recently published European and American guidelines for the diagnosis and treatment of hypertension].
    van Zwieten PA; Struijker Boudier HA; de Leeuw PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):868-71. PubMed ID: 15152386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Better blood pressure control: how to combine drugs.
    Brown MJ; Cruickshank JK; Dominiczak AF; MacGregor GA; Poulter NR; Russell GI; Thom S; Williams B;
    J Hum Hypertens; 2003 Feb; 17(2):81-6. PubMed ID: 12574784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy.
    Burnier M
    Am J Hypertens; 2006 Nov; 19(11):1190-6. PubMed ID: 17070434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
    Ceral J; Solar M
    Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.